Zynerba Pharmaceuticals Inc (ZYNE) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Zynerba Pharmaceuticals Inc   (NASDAQ: ZYNE)


Zynerba Pharmaceuticals Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zynerba Pharmaceuticals Inc's ROI in the second quarter of 2023?
Zynerba Pharmaceuticals Inc recorded a cumulative net loss of $-38 million during 12 months ending in the second quarter of 2023, resulting in a negative return on investment (ROI) of -89.84%.

Within the Healthcare sector 810 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2023 from 3792 to 4551.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM -38.78 % -35.59 % -33.62 % -23.64 % -12.17 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 29 39 46 53 57
Return On Investment (TTM) -89.84 % -74.89 % -63.06 % -58 % -55.24 %
ZYNE's Overall Ranking # 4551 # 3792 # 4121 # 0 # 0
Seq. Investment Change TTM -14.54 % -11.9 % -10.08 % -9.57 % -10.09 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -38 -37 -35 -36 -38

ZYNE Company Profile >> Back to ZYNE Roi Comparisons >> See Annual ZYNE Return On Investment



Return On Investment ZYNE's Ranking
Within: No.
Industry # 373
Sector # 811
Overall # 4551

Return On Investment Statistics
High Average Low
-20.62 %
-55.43 %
-89.84 %
(Mar 31 2017)   (Jun 30 2023)







Financial Statements
Zynerba Pharmaceuticals Inc's II. Quarter Investments $ 29 Millions ZYNE's Balance sheet
Zynerba Pharmaceuticals Inc's II. Quarter Income $ -11 Millions Quarterly ZYNE's Income Statement
ZYNE's Income by Division See ZYNE's Income by Division


ZYNE Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 46 71 60 76 58
Y / Y Investment Growth -34.97 % 18.49 % -20.56 % 31.43 % -6.51 %
Net Income in Millions -35 -37 -51 -33 -40
Y / Y Net Income Growth - - - - -
Annual Return On Investment -75.59 % -52.35 % -85.36 % -43.51 % -69.29 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZYNE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZYNE's Competitors
Subscribers only: Roi for Zynerba Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ZYNE's Customers

Other Ratios
ZYNE's Roa ZYNE's Inventory Turnover Ratio ZYNE's Growth Rates ZYNE's Dividend Statistics
ZYNE's Profitability Ratios ZYNE's Asset Turnover Ratio ZYNE's Dividend Growth
ZYNE's Roe ZYNE's Valuation Ratios ZYNE's Financial Strength Ratios ZYNE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.